Oncologic Disease
11
2
3
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (11)
"ADEN Platform: Pilot Clinical Validation for Chronic Disease Risk Stratification in Colombia"
A Two-Way Path to Health: Environmental Influences on Skeletal Muscle Endocrine Function
OUTPATIENT CANCER PATIENTS: THE RELATIONSHIP BETWEEN INFORMATION OVERLOAD, SYMPTOM SEVERITY, AND EMPOWERMENT LEVEL
Comparing the Effects of Art Therapy and Mandala Application on State Anxiety Levels in Chemotherapy Patients
Adapted Physical Activity (APA) Following Hospitalization in Frail Older Adults
Changes in Value-Based Assessment in Patients Undergoing Major Oncological Surgery
Incidence and Risk Factors of Post-Induction Hypotension in Geriatric Cancer Patients
Biodistribution and Pathophysiology Study of 11C-para-aminobenzoic Acid
Biodistribution and Pathophysiology Study of 18F-Fluorodeoxysorbitol (18F-FDS) in Diseased Patients
Oral Cryotherapy Applied to Patients Undergoing Chemotherapy
Molecular Characterizazion and Biological Samples Centralisation of Patients Affected by Oncoematolofic Pathology